Royalty Pharma plc
RPRX
Classement en actions
#860
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Prix de l'action
$62.20
Dernière synchronisation: 2026-10-21
Capitalisation boursière
$27.69B
Changement (1 jour)
-0.09%
Changement (1 an)
68.82%
Pays
US
Échange Royalty Pharma plc (RPRX)
Catégorie
Healthcare
Historique du prix de l'action pour Royalty Pharma plc (RPRX)
Prix de clôture le plus élevé : $58.43 le 2026-10-01
Prix de clôture le plus bas : $49.50 le 2020-06-01
Prix de clôture le plus bas : $49.50 le 2020-06-01
Historique du prix de l'action de Royalty Pharma plc de 2020 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | 27.24% |
| 2025 | 52.96% |
| 2024 | -9.35% |
| 2023 | -31.53% |
| 2022 | 5.51% |
| 2021 | -14.39% |
| 2020 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $45.29 | 34.87% |
SE
|
|
| $170.14 | 23.02% |
FR
|
|
| $116.39 | 58.03% |
US
|
|
| $59.52 | -0.48% |
IT
|
|
| $0.63 | -31.50% |
HK
|
